Scarfone Hugo A, Rodríguez Emilia C, Riera Jerónimo, Rufiner Maira, Charles Martín
Clínica de Ojos de Tandil, Av. Santamarina 760, Tandil B7000, Argentina.
Centro Oftalmológico Charles, Buenos Aiers C1116, Argentina.
Life (Basel). 2025 Jan 7;15(1):64. doi: 10.3390/life15010064.
The aim of this study was to evaluate visual outcomes and patient satisfaction after bilateral implantation of a new hydrophobic acrylic intraocular lens called Clareon (Alcon) using the mini-monovision technique.
A single-center, prospective, nonrandomized study was conducted in Tandil (Buenos Aires, Argentina), including patients scheduled for cataract surgery. To achieve mini-monovision, the spherical equivalent was calculated between -0.25 and +0.25 D for the dominant eye, and between -0.75 and -1.00 D for the non-dominant eye. The main outcomes were uncorrected distance visual acuity (UDVA) and uncorrected intermediate visual acuity (UIVA) evaluated at 66 cm. A secondary outcome, patient satisfaction, was assessed using the CatQuest-9SF questionnaire.
The mean binocular UDVA was 0.01 ± 0.05 logMAR three months after surgery, while the mean binocular UIVA was 0.20 ± 0.06 logMAR. The postoperative mean spherical equivalent in the dominant eye was -0.27 ± 0.12, and in the non-dominant eye was -0.87 ± 0.25. Before surgery, the CatQuest-9SF questionnaire revealed that 83.33% of patients were dissatisfied with their vision during daily activities. Over 50% reported significant difficulties with reading newspapers, sewing, and reading TV subtitles. Additionally, 66.6% struggled with recognizing faces, 50% with seeing product prices, and 50% with walking on uneven ground. Post-surgery, most patients experienced improved vision for daily tasks, with no reports of high dissatisfaction or significant difficulties. Patients were quite satisfied with their vision for hobbies and TV subtitles, and very satisfied (90%) with seeing supermarket prices.
patients implanted with a new enhanced monofocal IOL using the mini-monovision technique showed improved distance and intermediate visual acuity, reduced need for glasses, and expressed a high degree of satisfaction.
本研究的目的是使用微单眼视力技术评估一种名为Clareon（爱尔康）的新型疏水性丙烯酸人工晶状体双眼植入后的视觉效果和患者满意度。
在坦迪尔（阿根廷布宜诺斯艾利斯）进行了一项单中心、前瞻性、非随机研究，纳入计划接受白内障手术的患者。为实现微单眼视力，优势眼的等效球镜度计算为-0.25至+0.25 D，非优势眼为-0.75至-1.00 D。主要结局是在66 cm处评估的未矫正远视力（UDVA）和未矫正中视力（UIVA）。次要结局患者满意度采用CatQuest-9SF问卷进行评估。
术后三个月双眼平均UDVA为0.01±0.05 logMAR，双眼平均UIVA为0.20±0.06 logMAR。优势眼术后平均等效球镜度为-0.27±0.12，非优势眼为-0.87±0.25。手术前，CatQuest-9SF问卷显示83.33%的患者对日常活动中的视力不满意。超过50%的患者报告在阅读报纸、缝纫和看电视剧字幕方面有显著困难。此外，66.6%的患者难以识别面孔，50%的患者难以看清商品价格，50%的患者在不平地面行走时有困难。手术后，大多数患者的日常任务视力有所改善，没有高不满意率或显著困难的报告。患者对业余爱好和电视剧字幕的视力相当满意，对看清超市商品价格非常满意（90%）。
采用微单眼视力技术植入新型增强型单焦点人工晶状体的患者，远视力和中视力得到改善，对眼镜的需求减少，并表现出高度的满意度。
